• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效核酸酶指导的慢病毒载体整合到人核糖体 DNA 基因座。

Efficient Nuclease-Directed Integration of Lentivirus Vectors into the Human Ribosomal DNA Locus.

机构信息

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.

Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany.

出版信息

Mol Ther. 2020 Aug 5;28(8):1858-1875. doi: 10.1016/j.ymthe.2020.05.019. Epub 2020 May 23.

DOI:10.1016/j.ymthe.2020.05.019
PMID:32504545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403359/
Abstract

Lentivirus vectors (LVs) are efficient tools for gene transfer, but the non-specific nature of transgene integration by the viral integration machinery carries an inherent risk for genotoxicity. We modified the integration machinery of LVs and harnessed the cellular DNA double-strand break repair machinery to integrate transgenes into ribosomal DNA, a promising genomic safe-harbor site for transgenes. LVs carrying modified I-PpoI-derived homing endonuclease proteins were characterized in detail, and we found that at least 21% of all integration sites localized to ribosomal DNA when LV transduction was coupled to target DNA cleavage. In addition to the primary sequence recognized by the endonuclease, integration was also enriched in chromatin domains topologically associated with nucleoli, which contain the targeted ribosome RNA genes. Targeting of this highly repetitive region for integration was not associated with detectable DNA deletions or negative impacts on cell health in transduced primary human T cells. The modified LVs characterized here have an overall lower risk for insertional mutagenesis than regular LVs and can thus improve the safety of gene and cellular therapy.

摘要

慢病毒载体 (LVs) 是基因转移的有效工具,但病毒整合机制对转基因的非特异性整合具有潜在的遗传毒性风险。我们对 LVs 的整合机制进行了修改,并利用细胞 DNA 双链断裂修复机制将转基因整合到核糖体 DNA 中,这是转基因的一个有前途的基因组安全港位点。携带改良的 I-PpoI 衍生同源内切酶蛋白的 LVs 被详细表征,我们发现当 LV 转导与靶 DNA 切割偶联时,至少 21%的所有整合位点定位于核糖体 DNA。除了内切酶识别的主要序列外,整合还富集于与核仁拓扑相关的染色质域中,核仁包含靶向核糖体 RNA 基因。这种高度重复区域的靶向整合与可检测的 DNA 缺失或对转导的原代人 T 细胞健康的负面影响无关。这里表征的修饰 LVs 与常规 LVs 相比,其插入突变的总体风险较低,因此可以提高基因和细胞治疗的安全性。

相似文献

1
Efficient Nuclease-Directed Integration of Lentivirus Vectors into the Human Ribosomal DNA Locus.高效核酸酶指导的慢病毒载体整合到人核糖体 DNA 基因座。
Mol Ther. 2020 Aug 5;28(8):1858-1875. doi: 10.1016/j.ymthe.2020.05.019. Epub 2020 May 23.
2
rDNA-directed integration by an HIV-1 integrase--I-PpoI fusion protein.HIV-1 整合酶—I-PpoI 融合蛋白指导的 rDNA 整合。
Nucleic Acids Res. 2013 Mar 1;41(5):e61. doi: 10.1093/nar/gks1438. Epub 2012 Dec 28.
3
Characterization of a new IN-I-PpoI fusion protein and a homology-arm containing transgene cassette that improve transgene expression persistence and 28S rRNA gene-targeted insertion of lentiviral vectors.鉴定新型 IN-I-PpoI 融合蛋白和包含同源臂的转基因盒,以改善慢病毒载体的转基因表达持久性和 28S rRNA 基因靶向插入。
PLoS One. 2023 Jan 20;18(1):e0280894. doi: 10.1371/journal.pone.0280894. eCollection 2023.
4
Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.使用长末端重复序列修饰的慢病毒载体以最小整合水平在小鼠小脑浦肯野细胞中转基因表达。
J Neurovirol. 2009 Sep;15(5-6):371-9. doi: 10.3109/13550280903214091.
5
Hybrid lentivirus-transposon vectors with a random integration profile in human cells.在人类细胞中具有随机整合模式的混合慢病毒-转座子载体。
Mol Ther. 2009 Jul;17(7):1205-14. doi: 10.1038/mt.2009.10. Epub 2009 Feb 24.
6
Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.高效整合缺陷型慢病毒载体介导的睡眠美人转座子在原代人细胞中的基因组整合特性比较分析。
Mol Ther. 2011 Aug;19(8):1499-510. doi: 10.1038/mt.2011.47. Epub 2011 Apr 5.
7
Integrase-defective lentiviral vectors: progress and applications.整合酶缺陷型慢病毒载体:进展与应用。
Gene Ther. 2010 Feb;17(2):150-7. doi: 10.1038/gt.2009.135. Epub 2009 Oct 22.
8
Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.由酵母Flp重组酶介导的慢病毒DNA环的基因组插入。
BMC Biotechnol. 2008 Aug 9;8:60. doi: 10.1186/1472-6750-8-60.
9
Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras.探索人工LEDGF嵌合体,实现更安全、更随机的慢病毒载体整合图谱
PLoS One. 2016 Oct 27;11(10):e0164167. doi: 10.1371/journal.pone.0164167. eCollection 2016.
10
Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy.理解慢病毒载体染色质靶向:致力于降低基因治疗的插入突变潜能。
Gene Ther. 2013 Jun;20(6):581-8. doi: 10.1038/gt.2012.88. Epub 2012 Nov 22.

引用本文的文献

1
Long Non-coding RNA Based Therapy for Cardiovascular Disease.基于长链非编码RNA的心血管疾病治疗方法
J Cardiovasc Transl Res. 2025 Sep 3. doi: 10.1007/s12265-025-10686-z.
2
Structure and biochemistry-guided engineering of an all-RNA system for DNA insertion with R2 retrotransposons.基于结构与生物化学指导的全RNA系统工程,用于利用R2反转录转座子进行DNA插入
Nat Commun. 2025 Jul 2;16(1):6079. doi: 10.1038/s41467-025-61321-z.
3
Biology and utilization of R2 retrotransposons.R2反转录转座子的生物学特性与应用

本文引用的文献

1
CAS9 is a genome mutator by directly disrupting DNA-PK dependent DNA repair pathway.Cas9 通过直接破坏 DNA-PK 依赖性 DNA 修复途径来实现基因组突变。
Protein Cell. 2020 May;11(5):352-365. doi: 10.1007/s13238-020-00699-6. Epub 2020 Mar 13.
2
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology.磨砺分子剪刀:基因编辑技术的进展
iScience. 2020 Jan 24;23(1):100789. doi: 10.1016/j.isci.2019.100789. Epub 2019 Dec 19.
3
Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
RNA Biol. 2025 Dec;22(1):1-8. doi: 10.1080/15476286.2025.2521890. Epub 2025 Jun 25.
4
Ribosome biogenesis: A central player in liver diseases.核糖体生物发生:肝脏疾病中的核心因素。
Genes Dis. 2025 Jan 4;12(5):101512. doi: 10.1016/j.gendis.2025.101512. eCollection 2025 Sep.
5
Approaches and applications in transdermal and transpulmonary gene drug delivery.经皮和经肺基因药物递送的方法与应用
Front Bioeng Biotechnol. 2025 Jan 15;12:1519557. doi: 10.3389/fbioe.2024.1519557. eCollection 2024.
6
In vivo placental gene modulation via sonoporation.通过声穿孔法进行体内胎盘基因调控。
Placenta. 2024 Oct 23. doi: 10.1016/j.placenta.2024.10.015.
7
Gene therapy and kidney diseases.基因治疗与肾脏疾病。
Mol Ther Methods Clin Dev. 2024 Sep 6;32(4):101333. doi: 10.1016/j.omtm.2024.101333. eCollection 2024 Dec 12.
8
Ethical implications of developing RNA-based therapies for cardiovascular disorders.开发用于心血管疾病的基于RNA的疗法的伦理意义。
Front Bioeng Biotechnol. 2024 Mar 15;12:1370403. doi: 10.3389/fbioe.2024.1370403. eCollection 2024.
9
Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci.利用真核逆转录元件蛋白将转基因插入人类安全位点。
Nat Biotechnol. 2025 Jan;43(1):42-51. doi: 10.1038/s41587-024-02137-y. Epub 2024 Feb 20.
10
Advancing breast cancer diagnosis with a near-infrared fluorescence imaging smart sensor for estrogen/progesterone receptor detection.利用近红外荧光成像智能传感器进行雌激素/孕激素受体检测,推进乳腺癌诊断。
Sci Rep. 2023 Nov 30;13(1):21086. doi: 10.1038/s41598-023-48556-w.
通过基于慢病毒衣壳的仿生纳米颗粒递呈 Cas9/sgRNA 核糖核蛋白(RNP),实现高效的“打了就跑”基因组编辑。
Nucleic Acids Res. 2019 Sep 26;47(17):e99. doi: 10.1093/nar/gkz605.
4
DNA double-strand break repair-pathway choice in somatic mammalian cells.体细胞核哺乳动物细胞中 DNA 双链断裂修复途径的选择。
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714. doi: 10.1038/s41580-019-0152-0. Epub 2019 Jul 1.
5
Targeted gene knockin in zebrafish using the 28S rDNA-specific non-LTR-retrotransposon R2Ol.使用28S rDNA特异性非LTR逆转座子R2Ol在斑马鱼中进行靶向基因敲入。
Mob DNA. 2019 May 22;10:23. doi: 10.1186/s13100-019-0167-2. eCollection 2019.
6
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
7
Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges.针对遗传性疾病的造血干细胞基因治疗:进展与挑战。
Nat Rev Drug Discov. 2019 Jun;18(6):447-462. doi: 10.1038/s41573-019-0020-9.
8
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.CRISPR-Cas9 基因组编辑诱导兆碱基级别的染色体大片段缺失。
Nat Commun. 2019 Mar 8;10(1):1136. doi: 10.1038/s41467-019-09006-2.
9
A large CRISPR-induced bystander mutation causes immune dysregulation.大规模 CRISPR 诱导的旁观者突变导致免疫失调。
Commun Biol. 2019 Feb 18;2:70. doi: 10.1038/s42003-019-0321-x. eCollection 2019.
10
Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.通过慢病毒样仿生纳米颗粒传递 SaCas9 mRNA 用于瞬时表达和高效基因组编辑。
Nucleic Acids Res. 2019 May 7;47(8):e44. doi: 10.1093/nar/gkz093.